Sridhar Arun R, Cheung Jim W, Lampert Rachel, Silva Jennifer N A, Gopinathannair Rakesh, Sotomonte Juan C, Tarakji Khaldoun, Fellman Mark, Chrispin Jonathan, Varma Niraj, Kabra Rajesh, Mehta Nishaki, Al-Khatib Sana M, Mayfield Jacob J, Navara Rachita, Rajagopalan Bharath, Passman Rod, Fleureau Yann, Shah Maully J, Turakhia Mintu, Lakkireddy Dhanunjaya
Cardiac Electrophysiology, Pulse Heart Institute, Multicare Health System, Tacoma, Washington, USA.
Division of Cardiology, Department of Medicine, Weill Cornell Medicine, New York, NY, USA.
Commun Med (Lond). 2024 Oct 29;4(1):218. doi: 10.1038/s43856-024-00618-4.
The rapid growth in consumer-facing mobile and sensor technologies has created tremendous opportunities for patient-driven personalized health management. The diagnosis and management of cardiac arrhythmias are particularly well suited to benefit from these easily accessible consumer health technologies. In particular, smartphone-based and wrist-worn wearable electrocardiogram (ECG) and photoplethysmography (PPG) technology can facilitate relatively inexpensive, long-term rhythm monitoring. Here we review the practical utility of the currently available and emerging mobile health technologies relevant to cardiac arrhythmia care. We discuss the applications of these tools, which vary with respect to diagnostic performance, target populations, and indications. We also highlight that requirements for successful integration into clinical practice require adaptations to regulatory approval, data management, electronic medical record integration, quality oversight, and efforts to minimize the additional burden to health care professionals.
面向消费者的移动和传感器技术的快速发展为患者驱动的个性化健康管理创造了巨大机遇。心律失常的诊断和管理尤其适合从这些易于获取的消费者健康技术中受益。特别是,基于智能手机和腕戴式的可穿戴心电图(ECG)和光电容积脉搏波描记术(PPG)技术可以促进相对廉价的长期心律监测。在此,我们回顾了目前可用的以及新兴的与心律失常护理相关的移动健康技术的实际效用。我们讨论了这些工具的应用,这些应用在诊断性能、目标人群和适应症方面各不相同。我们还强调,成功整合到临床实践中的要求需要适应监管批准、数据管理、电子病历整合、质量监督,以及努力将对医疗保健专业人员的额外负担降至最低。